Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs BioNano Genomics Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while BioNano Genomics Inc trades at $1.2 (market cap $13.66M). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 11530.7× BioNano Genomics Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BBVA | BNGO | |
|---|---|---|
Market Cap | $157.51B | $13.66M |
Sector | Financials | Health |
52-Week High | $28.50 | $4.92 |
52-Week Low | $17.96 | $1.06 |
Dividend Yield | 3.8% | — |
Enterprise Value | — | $16.26M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
